{"id":"https://openalex.org/W2804669447","doi":"https://doi.org/10.1097/mjt.0000000000000778","title":"Intravenous Immunoglobulin Therapy in Refractory Autoimmune Dysautonomias: A Retrospective Analysis of 38 Patients","display_name":"Intravenous Immunoglobulin Therapy in Refractory Autoimmune Dysautonomias: A Retrospective Analysis of 38 Patients","publication_year":2018,"publication_date":"2018-05-18","ids":{"openalex":"https://openalex.org/W2804669447","doi":"https://doi.org/10.1097/mjt.0000000000000778","mag":"2804669447","pmid":"https://pubmed.ncbi.nlm.nih.gov/29781817"},"language":"en","primary_location":{"id":"doi:10.1097/mjt.0000000000000778","doi":"https://doi.org/10.1097/mjt.0000000000000778","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mjt.0000000000000778","pdf_url":null,"source":{"id":"https://openalex.org/S67118044","display_name":"American Journal of Therapeutics","issn_l":"1075-2765","issn":["1075-2765","1536-3686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072261110","display_name":"Jill R. Schofield","orcid":"https://orcid.org/0000-0002-0053-3996","observed_orcids":["https://orcid.org/0000-0002-0053-3996"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jill R. Schofield","raw_affiliation_strings":["Department of Medicine, Denver University of Colorado Anschutz Medical Campus, Aurora, CO; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Denver University of Colorado Anschutz Medical Campus, Aurora, CO; and","institution_ids":["https://openalex.org/I51713134","https://openalex.org/I921990950"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081134026","display_name":"Kamal R. Ch\u00e9mali","orcid":"https://orcid.org/0000-0003-4638-7784","observed_orcids":["https://orcid.org/0000-0003-4638-7784"]},"institutions":[{"id":"https://openalex.org/I156802259","display_name":"Eastern Virginia Medical School","ror":"https://ror.org/056hr4255","country_code":"US","type":"education","lineage":["https://openalex.org/I156802259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kamal R. Chemali","raw_affiliation_strings":["Department of Neurology, Eastern Virginia Medical School, Norfolk, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Eastern Virginia Medical School, Norfolk, VA","institution_ids":["https://openalex.org/I156802259"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5072261110"],"corresponding_institution_ids":["https://openalex.org/I51713134","https://openalex.org/I921990950"],"apc_list":null,"apc_paid":null,"fwci":4.7247,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.96008054,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"26","issue":"5","first_page":"e570","last_page":"e582"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11950","display_name":"Cardiovascular Syncope and Autonomic Disorders","score":0.6484000086784363,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11950","display_name":"Cardiovascular Syncope and Autonomic Disorders","score":0.6484000086784363,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":0.22669999301433563,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11627","display_name":"Autoimmune Neurological Disorders and Treatments","score":0.09229999780654907,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/postural-orthostatic-tachycardia-syndrome","display_name":"postural orthostatic tachycardia syndrome","score":0.9980000257492065},{"id":"https://openalex.org/keywords/gastrointestinal-motility-disorders","display_name":"gastrointestinal motility disorders","score":0.9919999837875366},{"id":"https://openalex.org/keywords/antiphospholipid-antibodies","display_name":"antiphospholipid antibodies","score":0.9580000042915344},{"id":"https://openalex.org/keywords/functional-capacity","display_name":"functional capacity","score":0.46799999475479126},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6520000100135803},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5400000214576721}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9602490663528442},{"id":"https://openalex.org/C2779543035","wikidata":"https://www.wikidata.org/wiki/Q620639","display_name":"Dysautonomia","level":3,"score":0.7887260913848877},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5617518424987793},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5558319687843323},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5554752349853516},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4935797452926636},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3666203022003174},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32056286931037903},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08586445450782776},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017152","descriptor_name":"Antibodies, Antiphospholipid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017152","descriptor_name":"Antibodies, Antiphospholipid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D020274","descriptor_name":"Autoimmune Diseases of the Nervous System","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D020274","descriptor_name":"Autoimmune Diseases of the Nervous System","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020274","descriptor_name":"Autoimmune Diseases of the Nervous System","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D054969","descriptor_name":"Primary Dysautonomias","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D054969","descriptor_name":"Primary Dysautonomias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054969","descriptor_name":"Primary Dysautonomias","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/mjt.0000000000000778","doi":"https://doi.org/10.1097/mjt.0000000000000778","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mjt.0000000000000778","pdf_url":null,"source":{"id":"https://openalex.org/S67118044","display_name":"American Journal of Therapeutics","issn_l":"1075-2765","issn":["1075-2765","1536-3686"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Therapeutics","raw_type":"journal-article"},{"id":"pmid:29781817","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29781817","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1572020852","https://openalex.org/W1668852558","https://openalex.org/W1937520182","https://openalex.org/W1991458707","https://openalex.org/W2014438197","https://openalex.org/W2022790525","https://openalex.org/W2033241122","https://openalex.org/W2035058661","https://openalex.org/W2036602163","https://openalex.org/W2042692206","https://openalex.org/W2051300855","https://openalex.org/W2054138854","https://openalex.org/W2075406880","https://openalex.org/W2084452572","https://openalex.org/W2090599558","https://openalex.org/W2090713933","https://openalex.org/W2092710817","https://openalex.org/W2100637118","https://openalex.org/W2102354104","https://openalex.org/W2112537841","https://openalex.org/W2127776176","https://openalex.org/W2129504431","https://openalex.org/W2132052942","https://openalex.org/W2133700167","https://openalex.org/W2138886795","https://openalex.org/W2143077460","https://openalex.org/W2143409320","https://openalex.org/W2148546756","https://openalex.org/W2152830608","https://openalex.org/W2160380540","https://openalex.org/W2169905474","https://openalex.org/W2288009061","https://openalex.org/W2344307377","https://openalex.org/W2414153112","https://openalex.org/W2582443999","https://openalex.org/W2605168872","https://openalex.org/W2691795141","https://openalex.org/W2752538395","https://openalex.org/W2783415133","https://openalex.org/W6704754584"],"related_works":["https://openalex.org/W4367297086","https://openalex.org/W4417519757","https://openalex.org/W4280584993","https://openalex.org/W2606824057","https://openalex.org/W3116137031","https://openalex.org/W51787081","https://openalex.org/W2521133110","https://openalex.org/W2915335395","https://openalex.org/W4396831514","https://openalex.org/W4394599296"],"abstract_inverted_index":{"BACKGROUND:":[0],"Intravenous":[1],"immunoglobulin":[2],"(IVIG)":[3],"has":[4,14],"recognized":[5],"efficacy":[6,31],"in":[7,23,36,142,216,233,251,270,291],"autoimmune":[8,24,41,206],"peripheral":[9],"nerve":[10],"disorders,":[11],"but":[12,224],"there":[13],"been":[15],"limited":[16],"study":[17],"of":[18,21,34,92,126,168,184,193,221,237,254],"the":[19,30,104,143,190],"use":[20],"IVIG":[22,35,83,134,246,265],"dysautonomias.":[25],"STUDY":[26,52],"QUESTION:":[27],"To":[28],"determine":[29],"and":[32,49,61,111,123,210,219,227,235,249,259,279,284,294],"safety":[33],"patients":[37,44,178,255,273,293],"with":[38,45,55,82,256,296],"disabling,":[39],"refractory":[40,276],"dysautonomias,":[42],"including":[43],"postural":[46],"tachycardia":[47],"syndrome":[48],"gastrointestinal":[50],"dysmotility.":[51],"DESIGN:":[53],"Patients":[54],"one":[56],"or":[57,72],"more":[58],"autonomic":[59,106,145,257],"disorder(s)":[60],"persistent":[62],"serological":[63],"evidence":[64,244,260],"for":[65,78,84,176,261],"autoimmunity":[66],"who":[67,274],"were":[68,80,118,199,214,231],"unable":[69],"to":[70,165,172,174,189,277,301],"work":[71],"attend":[73],"school":[74],"despite":[75],"usual":[76],"treatments":[77],"dysautonomia":[79,207],"treated":[81],"at":[85,89,93,138,180],"least":[86,94,139,181],"3":[87],"months":[88],"a":[90,112,166,252,297],"dose":[91],"1":[95,182],"gm/kg":[96],"monthly.":[97],"MEASURES":[98],"AND":[99],"OUTCOMES:":[100],"Outcome":[101],"measures":[102],"included":[103],"composite":[105,144],"symptom":[107,146],"scale":[108,147],"31":[109,148],"survey":[110],"functional":[113,150,156],"ability":[114,151,157],"score.":[115,152],"RESULTS:":[116],"There":[117,198,241],"38":[119],"patients,":[120,130,222,238],"84%":[121],"female":[122],"mean":[124,154,167,187],"age":[125],"28.4":[127],"years.":[128],"Of":[129],"83.5%":[131],"improved":[132,164],"on":[133],"as":[135],"defined":[136],"by":[137],"20%":[140],"improvement":[141],"and/or":[149],"The":[153,186,204],"pretreatment":[155],"score":[158],"was":[159,195],"21%":[160],"(mostly":[161],"bedridden),":[162],"which":[163],"74%":[169],"(nearing":[170],"able":[171],"return":[173],"work/school)":[175],"responsive":[177],"after":[179],"year":[183],"IVIG.":[185,302],"time":[188],"first":[191],"sign":[192],"response":[194,299],"5.3":[196],"weeks.":[197],"no":[200],"serious":[201],"adverse":[202],"events.":[203],"Mayo":[205],"panel":[208],"antibodies":[209,213,226,230,283,287],"traditional":[211],"Sj\u00f6gren":[212,229,286],"present":[215,232,290],"only":[217],"13%":[218],"8%":[220],"respectively,":[223],"antiphospholipid":[225],"novel":[228,285],"76%":[234],"42%":[236],"respectively.":[239],"CONCLUSIONS:":[240],"is":[242,247],"increasing":[243],"that":[245],"safe":[248],"effective":[250],"subset":[253],"disorders":[258],"autoimmunity.":[262],"A":[263],"4-month":[264],"trial":[266],"should":[267],"be":[268],"considered":[269],"severely":[271],"affected":[272],"are":[275,288],"lifestyle":[278],"pharmacological":[280],"therapies.":[281],"Antiphospholipid":[282],"often":[289],"these":[292],"correlate":[295],"high":[298],"rate":[300]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-01T00:00:00"}